Features

Combination Therapy Is Hard to Resist
Is combination therapy effective for the management of chronic hepatitis B? Find out what combination trials have discovered.

Cross-Resistance Chart of Current HBV Drugs

HepDART: Growing in Size and Influence
An Interview with Meeting Founder Dr. Raymond Schinazi

HBF Presents Symposium at HepDART 2007 on Liver Cancer Detection and Treatment
HepDART is the premier meeting in the field of hepatitis drug development and the HBF had its say by sponsoring a symposium on liver cancer, which is a controversial and important topic.

Support the Believe in the Cure Cycling Tour to Benefit the Hepatitis B Foundation!
On June 2, 2008, 17-year-old John Ellis will embark on the inaugural Believe in the Cure Cycling Tour, a 1,100-mile bike tour to raise awareness about hepatitis B and funds for the HBF.

Celebrating the 30th Anniversary of the Discovery of HDV
Highlights by John Taylor, Ph.D., HDV session Co-organizer

Spotlight on HBV-HIV Co-Infections
Finding the irresistible combination of right drug, right time, right patient

"Aha" Moments for Parents
By Bambi Winkler

HBV Could Be Key to Millions of Missing Women
The mystery behind one of Blumberg’s seminal observations in the 1970s: Parents who carried HBV tended to have more boys than girls.

True Gathering of Friends
B Informed Patient Conference, June 8-10, 2007 in Philadelphia, By: Karin Koelle

Underestimation of Chronic Hepatitis B in the U.S.
HBF Call for All Americans to B Counted

Congressional Briefing on Asian and Pacific Islander Health

Dr. Francis V. Chisari Honored for Outstanding Contributions

No Better Time to Visit the Foundation

Viral Load is a Good Long Term Predictor of Mortality in Chronic Hepatitis B
Alison Evans, Sc.D., Director of Public Health Research, Hepatitis B Foundation and Assistant Professor, Drexel University School of Public Health

AIM for the B Draws Positive Media Attention
Coincides with National Hepatitis B Awareness Week

Library of Congress Symposium Highlights

Making Noise in the Library!
HBF Co-Sponsors Historic Library of Congress Symposium on HIV and HBV

National Hepatitis Awareness Month

Biomarker Beauty Contest
HBF Princeton Workshop Focuses on Early Detection of Liver Cancer

International HBV Meeting 2006 Highlights

Nobel Laureate Dr. Baruch Blumberg Joins HBF As First “Distinguished Scholar”

New Era of Progress
HBF creates and opens the Pennsylvania Biotech Center of Bucks County

U.S. Treatment Guidelines for Chronic Hepatitis B Updated
By Emmet B. Keeffe, et. al, in Clinical Gastroenterology and Hepatology, August 2006

HBV Viral Loads
How Low Must We Go?

Making Hepatitis B Therapy Irresistible
Experts at NIH Meeting agree key concern is to avoid drug resistance.

One Million Missing Americans with Chronic HBV
The Hepatitis B Foundation speculates high risk communities may not “B Counted” in U.S. estimates. Read why...

Everyone’s Talking about Hepatitis B
Hepatitis B Makes Trans-Atlantic Splash HepDART 2005 Showcases HBV Therapies HBV 2005 Features Innovative Research

Turkey Tackles Dual Health Threat: Hepatitis B and D
In Turkey, hepatitis B is one of the main health problems facing the country.

New HBV Bill – Call to Action!
HBV Bill Reaches Congressional Floor

If You Have Hepatitis B and Want To Pursue A Medical Career,
Read this Article First...

Physician with HBV Denied Professional Choice

HBV, Immigration and You: Don’t Ask, Don’t Tell
What are the immigration laws concerning hepatitis B?

“AIM for the B” Puts Hepatitis B in the National Spotlight
First National Hepatitis B Awareness Week and Congressional Briefing

  Copyright ©2008 Baldwin Publishing, (800) 705-6522.